WHO Pandemic Flu Deal Doesn’t Go Far Enough, NGOs Say
Two civil society groups said the recent World Health Organization agreement on influenza pandemic strategy is an improvement on the present situation but has key shortcomings.
Original news and analysis on international IP policy
Two civil society groups said the recent World Health Organization agreement on influenza pandemic strategy is an improvement on the present situation but has key shortcomings.
Niels Louwaars of the Centre for Genetic Resources, Wageningen University, The Netherlands, discusses the importance of plant breeder’s rights. He makes the case for a carefully balanced protection for plant breeders and changes to patents in agriculture, in order to ensure a competitive, diversified supply of plant varieties and seeds.
Free culture leader and Harvard University law professor Larry Lessig was at the European Organization for Nuclear Research (CERN) yesterday to talk about access to scientific knowledge on internet. In the symbolic place where the World Wide Web was invented and where scientists are now trying to unravel the creation of the universe, Lessig praised CERN’s open access initiative and in this temple of reasoning, said the copyright architecture was on the edge of absurdity.
After a week of discussions, a good part of which centred around intellectual property issues, World Health Organization members agreed to a framework aimed at better addressing future influenza pandemics and facilitating vaccines access for developing country populations, with industry contributions.
World Health Organization members trying this week to agree on elements of a framework for helping the world address the next influenza pandemic headed into the final night of the meeting in intensive negotiations. At press time, negotiations were focused on specifics of standard agreements for the transfer of genetic materials related to flu virus strains.
A hundred years ago, Dutch physicist Heike Kamerlingh Onnes and his student Gilles Holst discovered a property that was to launch decades of fervent research to understand the phenomenon: Superconductivity. Today, researchers are still trying to find ways to use this remarkable property, but are celebrating the centenary of its discovery.
Three United Nations agencies have joined together to explain to their member countries the little-understood but hard-won flexibilities to applying stiff international intellectual property rules. The focus of the new policy brief is on improving access to HIV treatment, and it offers a series of actions for governments and international organisations.
The use of arbitration across the Caribbean has been largely within the context of trade union disputes and is still something of a novelty in resolving commercial and private disputes in the region, Abiola Inniss writes.
The newly created Medicines Patent Pool promises to increase access to HIV/AIDS medications in developing markets. Based in Geneva, Switzerland, the pool operates a scheme in which pharmaceutical patent holders voluntarily licence their drugs to generic manufacturers who then produce more affordable versions for patients in poorer countries
The Canadian Parliament is on the verge of amending the nation’s patent regime to make it easier for generic drug companies to provide low-cost HIV medications for developing countries.
The new international agreement on access and benefit-sharing of genetic resources has many IP implications, according to panellists at an event last week. And at least one United Nations agency is launching an effort to help countries with those IP implications.

Benny Spiewak writes: There used to be a time when Brazil meant almost exclusively Carnival, Samba and Soccer. Well, those days are over and there is an undeniable message that will echo through the knowledge-based, creative, innovative world: Wake-Up, World, It’s Tropicalization Time!